Not applicableStudy completedNCT02607371What this trial is testingAnticoagulation Preference by AF Patients StudyWho this might be right forAtrial Fibrillation Bayer 198
Not applicableNot Yet RecruitingNCT06884384What this trial is testingDOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort StudyWho this might be right forAntiphospholipid Syndrome (APS)Cohort StudyThrombotic and Bleeding Events Central Hospital, Nancy, France 310
Not applicableStudy completedNCT02596230What this trial is testingRE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous ThromboembolismWho this might be right forVenous Thromboembolism Boehringer Ingelheim 7,797
Not applicableStudy completedNCT03826927What this trial is testingNew Oral Anticoagulants (NOAC) in Stroke PatientsWho this might be right forStrokeAtrial Fibrillation University Hospital, Basel, Switzerland 1,023
Not applicableStudy completedNCT04518735What this trial is testingEvolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)Who this might be right forCovid19 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,707
Not applicableStudy completedNCT02687867What this trial is testingReal-world Comparative Effectiveness of Dabigatran Versus Vitamin K AntagonistWho this might be right forAtrial Fibrillation Bayer 56,039
Not applicableStudy completedNCT02687854What this trial is testingReal-world Comparative Effectiveness of Apixaban Versus Vitamin K AntagonistWho this might be right forAtrial Fibrillation Bayer 18,591
Post-approval studies (Phase 4)Study completedNCT01727453What this trial is testingCompare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.Who this might be right forAcute Gastrointestinal Bleeding Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40
Not applicableStudy completedNCT02611635What this trial is testingAtrial Fibrillation Patient Preference StudyWho this might be right forAtrial Fibrillation Bayer 382
Not applicableEnded earlyNCT03715725What this trial is testingA Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.Who this might be right forNon-valvular Atrial Fibrillation Bayer 70,000
Large-scale testing (Phase 3)Ended earlyNCT02618577What this trial is testingNon-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate EpisodesWho this might be right forAtrial High Rate Episodes Atrial Fibrillation Network 2,608
Large-scale testing (Phase 3)Study completedNCT01674647What this trial is testingExplore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for CardioversionWho this might be right forAtrial Fibrillation Bayer 1,504
Post-approval studies (Phase 4)Study completedNCT00860106What this trial is testingEcho Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment CessationWho this might be right forPrevious Vka TreatmentPrevious Proximal VTE University Hospital, Grenoble 222
Testing effectiveness (Phase 2)Study completedNCT00623779What this trial is testingAtrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)Who this might be right forPersistent or Permanent Non-valvular Atrial Fibrillation AstraZeneca 128
Large-scale testing (Phase 3)Study completedNCT02740335What this trial is testingStudy of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.Who this might be right forSignificant Bleeding Risk Octapharma 208
Post-approval studies (Phase 4)Study completedNCT03064035What this trial is testingFixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin ReversalWho this might be right forAcute Bleeding on Long-Term Anticoagulation TherapyHemorrhageSignificant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)+1 more HealthPartners Institute 79
Very early researchNot Yet RecruitingNCT07011095What this trial is testingDOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot TrialWho this might be right forAtrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation) Population Health Research Institute 100
Large-scale testing (Phase 3)Study completedNCT02664649What this trial is testingAnti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic StenosisWho this might be right forSymptomatic Aortic StenosisEligible for Transcatheter Aortic Valve Replacement Assistance Publique - Hôpitaux de Paris 1,510
Not applicableStudy completedNCT03462446What this trial is testingAnalysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists EventsWho this might be right forAtrial Fibrillation Bayer 249
Large-scale testing (Phase 3)UnknownNCT06143787What this trial is testingEffect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth ExtractionWho this might be right forBleeding From TeethBleeding Prophylaxis Hyloris Developments 280